Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $917,883 - $1.12 Million
16,197 Added 307.46%
21,465 $1.48 Million
Q4 2023

Feb 14, 2024

SELL
$49.38 - $63.75 $158,361 - $204,446
-3,207 Reduced 37.84%
5,268 $327,000
Q3 2023

Nov 14, 2023

SELL
$48.64 - $62.51 $8.29 Million - $10.7 Million
-170,519 Reduced 95.27%
8,475 $475,000
Q2 2023

Aug 14, 2023

SELL
$47.99 - $60.21 $1.37 Million - $1.72 Million
-28,556 Reduced 13.76%
178,994 $9.03 Million
Q1 2023

May 15, 2023

SELL
$52.6 - $67.34 $251,954 - $322,558
-4,790 Reduced 2.26%
207,550 $11.3 Million
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $2.41 Million - $3.1 Million
40,453 Added 23.53%
212,340 $13.3 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $6.73 Million - $9.07 Million
116,110 Added 208.17%
171,887 $12.1 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $1.59 Million - $2.6 Million
40,362 Added 261.84%
55,777 $3.16 Million
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $351,057 - $503,711
8,026 Added 108.62%
15,415 $965,000
Q4 2021

Feb 14, 2022

SELL
$50.01 - $73.35 $882,076 - $1.29 Million
-17,638 Reduced 70.48%
7,389 $414,000
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $152,702 - $202,864
2,579 Added 11.49%
25,027 $1.63 Million
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $833,391 - $1.08 Million
16,217 Added 260.26%
22,448 $1.42 Million
Q1 2021

May 17, 2021

SELL
$49.14 - $59.89 $3.02 Million - $3.68 Million
-61,468 Reduced 90.8%
6,231 $373,000
Q4 2020

Feb 16, 2021

BUY
$42.19 - $51.5 $2.14 Million - $2.62 Million
50,799 Added 300.59%
67,699 $3.38 Million
Q3 2020

Nov 16, 2020

SELL
$35.33 - $51.04 $163,436 - $236,111
-4,626 Reduced 21.49%
16,900 $863,000
Q2 2020

Aug 14, 2020

SELL
$22.91 - $39.83 $3,138 - $5,456
-137 Reduced 0.63%
21,526 $756,000
Q1 2020

May 15, 2020

SELL
$16.44 - $37.73 $312,968 - $718,266
-19,037 Reduced 46.77%
21,663 $550,000
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $796,499 - $1.18 Million
40,700 New
40,700 $1.13 Million
Q1 2019

May 15, 2019

SELL
$13.32 - $24.35 $15,131 - $27,661
-1,136 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$13.2 - $16.43 $14,995 - $18,664
1,136 New
1,136 $17,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.